Efficacy and safety of nafamostat mesilate in pediatric continuous renal replacement therapy: a 5-year retrospective study in South Korea

Hyunseung Noh, Heeyeon Cho, Jinwoon Joung

Open source

DOI
10.3339/ckd.26.011
Published
2026-06-30
Container
Childhood Kidney Diseases
Publisher
Korean Society of Pediatric Nephrology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3339/ckd.26.011,
  title = {Efficacy and safety of nafamostat mesilate in pediatric continuous renal replacement therapy: a 5-year retrospective study in South Korea},
  author = {Hyunseung Noh and Heeyeon Cho and Jinwoon Joung},
  year = {2026},
  journal = {Childhood Kidney Diseases},
  doi = {10.3339/ckd.26.011},
  url = {https://doi.org/10.3339/ckd.26.011}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of nafamostat mesilate in pediatric continuous renal replacement therapy: a 5-year retrospective study in South Korea
AU  - Hyunseung Noh
AU  - Heeyeon Cho
AU  - Jinwoon Joung
PY  - 2026
JO  - Childhood Kidney Diseases
DO  - 10.3339/ckd.26.011
UR  - https://doi.org/10.3339/ckd.26.011
ER  - 

APA

Noh, H., Cho, H., & Joung, J. (2026). Efficacy and safety of nafamostat mesilate in pediatric continuous renal replacement therapy: a 5-year retrospective study in South Korea. Childhood Kidney Diseases. https://doi.org/10.3339/ckd.26.011

Source records